Wegovy Price Reduction: What Has Actually Changed in the UK?

What the evidence tells us about Wegovy's cost landscape since 2025

The pricing backdrop shifted noticeably when Eli Lilly raised the UK list price for Mounjaro in September 2025, widely reported at the time, with the 15mg pen's list price rising from around £122 to around £330 per four-week pen. That move pulled Wegovy pricing into sharper focus, because the two medicines now sit at opposite ends of a visible range. Based on NICE's appraisal of semaglutide (TA875) and the broader private-market context, you can get a clearer sense of where things stand by looking at what Wegovy price ranges currently look like, with typical private costs falling roughly between £149 and £375 per month depending on dose and provider. Those figures are hedged deliberately: they reflect what's been reported, not a fixed tariff.

One development worth noting is the MHRA's approval of a dedicated single-dose 7.2mg Wegovy pen on 14 April 2026, the highest maintenance dose now available in the UK. Clinical trial data for 7.2mg reported around 20.7% average weight loss over 72 weeks, which starts to approach the results seen with tirzepatide 15mg in the STEP 1 trial published in the New England Journal of Medicine. Whether that new pen format affects private pricing more broadly remains to be seen. What is consistent: semaglutide treatment is not a flat price. You start at 0.25mg, and most people reach 2.4mg (or now 7.2mg) over several months. The dose you're on when you check a price is rarely the dose you'll stay on.

These are prescription-only medicines. Prices that appear on comparison sites often strip out the prescription fee, consultation charge or delivery cost, leaving a figure that looks lower than the real total. Anyone comparing options should also understand how semaglutide injection price is structured, since the NHS medicines page for semaglutide sets out what the medicine is and how it works, independent of any private pricing discussion, and the NHS medicines page for semaglutide covers that clearly.

What UK private pricing actually includes, and what often goes missing

A headline monthly price for Wegovy tells you little on its own. The questions that matter: does it include the prescriber's consultation? Is there a separate fee for the prescription itself? What happens when you need a dose increase, is there another charge? Is aftercare and clinical support part of the package, or billed separately? And what about delivery?

These are not niche concerns. Many providers charge for each of these elements separately, so a price that reads as competitive at the start of treatment can accumulate over the months it typically takes to reach a maintenance dose. For anyone exploring their full cost of Wegovy treatment over time, it's worth mapping out those components honestly before comparing headline figures.

The clinical layer matters too. Semaglutide 2.4mg is licensed for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition, lower thresholds can apply for some ethnic backgrounds under UK guidance. NICE recommends it within specialist services and for a maximum of two years; the private route sits outside that restriction, but the clinical assessment requirement remains identical. A prescriber still has to review your case, your health history and any medicines you take. That appointment has a cost. It should be in the price.

How nume prices Wegovy treatment (and why we don't lead on the lowest number

A real clinician reads your consultation the same day) not software, not a queue. If approved, your order is dispatched with DPD before 5pm on the day of approval (order by 12pm Monday to Friday), and it arrives the next working day in a plain box. Inside: your pen, clearly labelled, ready to refrigerate. That's the physical reality of what the price covers.

At nume, one price includes the consultation, the prescription, the medication, delivery and seven-day aftercare. There are no subscriptions and no auto-renewals. Every repeat order is reviewed by a prescriber before it goes out. We don't publish per-pen prices in this page's body copy, current treatment pricing is on our free consultation and treatment page.

We're not the cheapest option, and that's a deliberate choice. Running the clinical infrastructure properly (a GPhC-registered pharmacy with photo-ID verification, live weight checks on video, GP notification in line with GPhC guidance) costs money. The alternative is cutting corners that shouldn't be cut on a prescription medicine. You can verify us on the GPhC register at any point (registration number 9012878, verifiable at the GPhC pharmacy register).

For a more detailed breakdown of what private semaglutide costs and how those figures are built up, the Wegovy injection price guide covers the components in full.

Why 'cheapest' is the wrong question for a prescription-only medicine

The MHRA has been direct about the risks of buying GLP-1 medicines from unverified sources. Counterfeit Wegovy and Ozempic pens have been seized in the UK in significant quantities, fake pens have in some cases contained insulin rather than semaglutide, with serious consequences. The MHRA's Yellow Card scheme allows anyone to report a suspected counterfeit or a seller offering these medicines without a prescription. The MHRA's guidance is clear: if an online seller is offering a prescription medicine and the price looks far below the market, or there is no clinical assessment involved, that is a red flag.

Price is not an irrelevant factor, nobody should pay more than they have to for treatment. But the right comparison is not lowest-number vs. lowest-number. It's: what is the quality of the clinical oversight, is the supply chain licensed and verified, and does the price include everything that makes the treatment safe? Those are the metrics that protect you. It's also worth checking whether any Wegovy reduced price options are available to you, since some providers do offer lower costs at certain doses or through specific access routes.

If you're weighing up your options, our overview of Wegovy in the UK covers the full picture: how it works, who it's licensed for, what the evidence says and how to access it safely. Or if you'd like to explore semaglutide alongside tirzepatide, the weight-loss treatment overview sets out both options clearly.